In this video, Michael J. Bloch, MD, speaks about highlights from The American College of Cardiology 2022 conference in Washington DC, including sessions on inflammation, elevated lack of protein A and...
Several cardiology society guidelines recommend that infected cardiac implantable electronic devices and its leads be completely removed from all patients. Researchers examined adherence to these...
New research has shed light on the addition of clopidogrel to the rivaroxaban and aspirin regimen of patients with PAD. Let us know about your usual treatment course of action by taking our poll.
Are you familiar with the results of the eicosapentaenoic acid (EPA) analysis of the REDUCE-IT trial? Find out the effect of EPA on heart failure by taking our pop quiz.
In this video, Michael J. Bloch, MD, speaks about highlights from The American College of Cardiology 2022 conference in Washington DC, including sessions on inflammation, elevated lack of protein A and...
In this video, Deepak Bhatt, MD, MPH, overviews the findings from the eicosapentaenoic acid (EPA) analysis of the REDUCE-IT trial and what impact the results may have on the future of cardiovascular...
In this podcast, William R. Hiatt, MD, provides insight into a new subgroup analysis of the VOYAGER-PAD trial, which revealed whether adding clopidogrel to the rivaroxaban and aspirin regime of a patient...
